In Vitro Assay Service for Fibrosis Evaluation
We are delighted to announce the launch of our new in vitro assay service for fibrosis evaluation.
By launching this service, we now offer a cost-effective and efficient way to conduct preliminary studies and screen compounds for potential fibrotic effects, saving valuable time and resources in your drug development journey. This not only speeds up the early stages of your drug discovery process but also mitigates the risk associated with investing in full-scale animal studies prematurely.
Over the years, we have been conducted in providing premier drug efficacy evaluation study services, focusing on inflammation, fibrosis and oncology as a non-clinical CRO. We have been able to accelerate the drug development pipeline through this service and contribute to advancing many of the compounds for which no cure is yet available into clinical trials.
Should you have any questions or if you wish to discuss how this new service can benefit your current and future projects, please contact us.